These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2155736)

  • 1. Mechanism of action of 5-aminosalicylic acid and its derivatives.
    Ireland A; Jewell DP
    Clin Sci (Lond); 1990 Feb; 78(2):119-25. PubMed ID: 2155736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant properties of 5-aminosalicylic acid: potential mechanism for its protective effect in ulcerative colitis.
    Miles AM; Grisham MB
    Adv Exp Med Biol; 1995; 371B():1317-21. PubMed ID: 7502808
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I; Kawasaki M; Matsuda A; Kataoka M; Kokurba Y
    Arzneimittelforschung; 1998 Dec; 48(12):1163-7. PubMed ID: 9893931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis.
    Dallegri F; Ottonello L; Ballestrero A; Bogliolo F; Ferrando F; Patrone F
    Gut; 1990 Feb; 31(2):184-6. PubMed ID: 2155862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion.
    Staerk Laursen L; Stokholm M; Bukhave K; Rask-Madsen J; Lauritsen K
    Gut; 1990 Nov; 31(11):1271-6. PubMed ID: 2253912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aminosalicylic acid in the treatment of inflammatory bowel disease.
    Bondesen S; Rasmussen SN; Rask-Madsen J; Nielsen OH; Lauritsen K; Binder V; Hansen SH; Hvidberg EF
    Acta Med Scand; 1987; 221(3):227-42. PubMed ID: 3296672
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of salicylate derivatives for potential use in ulcerative colitis: proposal for a new action of 5-aminosalicylic acid?
    Roediger WE; Deakin EJ; Walker G; Nance SH
    Pharmacology; 1989; 39(1):39-45. PubMed ID: 2511578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis.
    Campieri M; Lanfranchi GA; Bertoni F; Brignola C; Bazzocchi G; Minguzzi MR; Labò G
    Digestion; 1984; 29(4):204-8. PubMed ID: 6381184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of intestinal leukotriene formation as a possible mechanism of action of sulfasalazine, 5-aminosalicylic acid and 4-aminosalicylic acid].
    Peskar BM
    Klin Wochenschr; 1988 Nov; 66(22):1147-50. PubMed ID: 2907066
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-ASA for ulcerative colitis.
    Meyers S; Janowitz HD
    N Engl J Med; 1988 Jun; 318(24):1620-1. PubMed ID: 3287160
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of ulcerative colitis with 5-aminosalicylic acid.
    Sninsky CA
    Ann Intern Med; 1993 Oct; 119(8):858-9. PubMed ID: 8379609
    [No Abstract]   [Full Text] [Related]  

  • 12. Pleuropericarditis in a patient with ulcerative colitis in longstanding 5-aminosalicylic acid therapy.
    Iaquinto G; Sorrentini I; Petillo FE; Berardesca G
    Ital J Gastroenterol; 1994 Apr; 26(3):145-7. PubMed ID: 8061342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of drugs on colonic eicosanoid accumulation in active ulcerative colitis.
    Eliakim R; Karmeli F; Chorev M; Okon E; Rachmilewitz D
    Scand J Gastroenterol; 1992 Nov; 27(11):968-72. PubMed ID: 1455196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis.
    Campieri M; Gionchetti P; Belluzzi A; Brignola C; Migaldi M; Tabanelli GM; Bazzocchi G; Miglioli M; Barbara L
    Dig Dis Sci; 1987 Dec; 32(12 Suppl):67S-70S. PubMed ID: 3319460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-aminosalicylic acid enemas in treatment of ulcerative colitis.
    Fedotin MS
    Mo Med; 1985 Jun; 82(6):301-3. PubMed ID: 4010664
    [No Abstract]   [Full Text] [Related]  

  • 16. 5-Aminosalicylic acid enemas in treatment of distal ulcerative colitis and proctitis in Canada.
    Sutherland LR; Martin F
    Dig Dis Sci; 1987 Dec; 32(12 Suppl):64S-66S. PubMed ID: 3319459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral mesalamine for ulcerative colitis.
    Med Lett Drugs Ther; 1992 Aug; 34(877):80-1. PubMed ID: 1353858
    [No Abstract]   [Full Text] [Related]  

  • 18. Choosing an oral 5-aminosalicylic acid preparation for ulcerative colitis.
    Drug Ther Bull; 1992 Jun; 30(13):50-2. PubMed ID: 1628539
    [No Abstract]   [Full Text] [Related]  

  • 19. IBD: which 5-ASA drug works where?
    Ferry GD
    J Pediatr Gastroenterol Nutr; 1993 May; 16(4):474-5. PubMed ID: 8315560
    [No Abstract]   [Full Text] [Related]  

  • 20. Ulcerative colitis.
    Am Pharm; 1992 Aug; NS32(8):27. PubMed ID: 1524018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.